Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Παρόμοια τεκμήρια

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  ανά: Mukhtyar, C, κ.ά.
  Έκδοση: (2006)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  ανά: Mukhtyar, C, κ.ά.
  Έκδοση: (2008)
• Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
  ανά: Saket Jha, κ.ά.
  Έκδοση: (2019-01-01)
• Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
  ανά: Zhi-Ying Li, κ.ά.
  Έκδοση: (2020-08-01)
• A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
  ανά: Mahmoud M. Mohamed, κ.ά.
  Έκδοση: (2023-07-01)